NEW YORK, March 27, 2017 -- Hanweck, a leading provider of real-time risk analytics on global derivatives markets, today announced that Terrence M. Belton, Managing Director and Head of Global Portfolio Strategy for the Chief Investment Office at JPMorgan Chase, has joined its Board of Directors. A distinguished economist, Dr. Belton in his current role oversees interest rate risk management for JPMorgan Chase as well as strategy around the firm’s investment portfolio.
Commenting on the appointment, Gerald A. Hanweck Jr., PhD, Founder and CEO of Hanweck, “Terry Belton has long been recognized as a thought leader in the area of portfolio risk management and analysis. As Hanweck expands our product suite to focus on solutions that go beyond instrument-level analytics and include comprehensive derivatives scenario analysis and portfolio stress testing, his insights and contributions to our Board will be extremely valuable.”
Dr. Belton added, “I’m honored to join Hanweck’s Board of Directors and look forward to working with the team at an exciting time for the company.”
Prior to assuming his current role, Dr. Belton was head of Global Fixed Income and FX Research at JPMorgan, and an Economist at the Federal Reserve Board in Washington D.C.
He is currently a member of the Treasury Borrowing Advisory Committee and the NY Fed Financial Advisory Roundtable. He is also an Adjunct Professor at the University of Chicago where he has taught in the Graduate School of Business since 1995. Dr. Belton is co-author of several books, including The Treasury Bond Basis and Eurodollar Futures and Options; Controlling Money Market Risk. Dr. Belton received a PhD in Economics from the University of Michigan and did his undergraduate studies at Boston College.
About Hanweck
Hanweck is the leading provider of real-time risk analytics on global derivatives markets focusing on the large-scale risk problems of banks, broker/dealers, hedge funds, central counterparties and exchanges -- where the number of instruments and positions number in the millions. Hanweck delivers its risk analytics as a real-time service -- usually in the form of a data feed -- thereby dramatically simplifying integration with its customers' risk architecture. Hanweck's institutional investors include Nasdaq and Argentum, a New York-based private equity firm. For more information, please visit www.hanweck.com or follow Hanweck on Twitter and LinkedIn.
Contact Information Media/Marketing: Molly McGregor, [email protected] Sales/Business Development: [email protected]


Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 



